网站主页>>>项目整合精选>>>项目整合精选>>>Moxantrazole, Teloxantrone, DuP-937, CI-937, PD-113309, NSC-355644

Moxantrazole, Teloxantrone, DuP-937, CI-937, PD-113309, NSC-355644

替洛蒽醌 6-羟基-2-{2-[(2-羟基)氨基]乙基}-5-{[2-(甲基氨基)乙基]氨基}-1,2-二氢二苯并[CD,G]勻唑-7,10-二盐酸二酮 Chemical Name: 7,10-Dihydroxy-2-[2-[(2-hydroxyethyl)amino]ethyl]-5-[[2-(methylamino)ethyl]amino]anthra[1,9-cd]pyrazol-6(2H)-one
CAS No. 91441-48-4, 132937-88-3 (diHCl salt, monohydrate), 91450-82-7 (HBr salt)
项目整合开发状态: Phase II
项目研究机构: Pfizer (Originator), Bristol-Myers Squibb (Licensee)
合成路线:Treatment of 1,4-dichloro-5,8-dihydroxy-9,10-anthracenedione (I) with K2CO3 and benzyl bromide gives the benzyl ether (II) in refluxing acetone,which,followed by treatment with 2-[(2-hydrazinoethyl)amino]ethanol in anhydrous Me2SO,gives product (III).Treatment of product (III) with excess [(2-aminoethyl)amino]methane in refluxing pyridine gives the 玹wo armed?compound,which,followed by treatment with Pearlman's catalyst in glacial AcOH,gives the target compound CI-937.
📌 参考资料/链接:
参考文献标题:CI-937 and CI-942
文献作者:Hoshi,A.
参考来源:Drugs Fut 1986,11(3),179

📄 详细内容


合成路线:Treatment of 1,4-dichloro-5,8-dihydroxy-9,10-anthracenedione (I) with K2CO3 and benzyl bromide gives the benzyl ether (II) in refluxing acetone,which,followed by treatment with 2-[(2-hydrazinoethyl)amino]ethanol in anhydrous Me2SO,gives product (III).Treatment of product (III) with excess [(2-aminoethyl)amino]methane in refluxing pyridine gives the 玹wo armed?compound,which,followed by treatment with Pearlman's catalyst in glacial AcOH,gives the target compound CI-937.

合成路线:1,4-Dichloro-5-hydroxy-9,10-anthracenedione (I) is alkylated with powdered potassium carbonate and benzyl bromide to give the ether (II).The ether is condensed with threee equivalents of 2-[(2-hydrazinoethyl)amino]ethanol in anhydrous dimethylsulfoxide to give regioisomers (III) and (IV),which are separated by flash silica gel chromatography.The isomer (III) is reacted with an excess of 2-[(2-aminoethyl)amino]ethanol in refluxing pyridine to give the intermediate (V).The intermediate is converted to the 10-hydroxy isomer by hydrogenolysis of the benzyl protecting group with Pearlman's catalyst in glacial acetic acid,followed by dihydrochloride salt formation.

参考文献标题:5-[(Aminoalkyl)amino]-substituted anthra[1,9-cd]pyrazol-6(2H)-ones as novel anticancer agents.Synthesis and biological evaluation
文献作者:Showalter,H.D.H.; Johnson,J.L.; Werbel,L.M.; Leopold,W.R.; Jackson,R.C.; Elslager,E.F.
参考来源:J Med Chem 1984,27(3),253-5


合成路线:Treatment of 1,4-dichloro-5,8-dihydroxy-9,10-anthracenedione (I) with K2CO3 and benzyl bromide gives the benzyl ether (II) in refluxing acetone,which,followed by treatment with 2-[(2-hydrazinoethyl)amino]ethanol in anhydrous Me2SO,gives product (III).Treatment of product (III) with excess [(2-aminoethyl)amino]methane in refluxing pyridine gives the 玹wo armed?compound,which,followed by treatment with Pearlman's catalyst in glacial AcOH,gives the target compound CI-937.
参考文献标题:
文献作者:
参考来源:Proc Amer Assoc Cancer Res 1984,25(1),352


产品链接: CAS No. 91441-48-4››

产品链接: CAS No.132937-88-3››